Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review
  • Published:

Is active surveillance a suitable option for African American men with prostate cancer? A systemic literature review

Prostate Cancer and Prostatic Diseases volume 20, pages 127–136 (2017)Cite this article

Subjects

Abstract

Background:

Certain patients presenting with either low or very-low-risk prostate cancer (PCa) can represent a therapeutic dilemma for physicians. The oncologic outcomes of active surveillance (AS) for men with very-low-risk PCa are overall excellent. However, there are concerns about AS related to the potential for upgrading or upstaging. The African American (AA) population is under-represented in studies evaluating AS outcomes and this is particularly important because of the unique epidemiology of PCa in AA men.

Methods:

A literature review through the Medline database published from 1990 until August 2015 was performed to identify studies reporting outcomes of the AA population with low-risk PCa that underwent either AS or treatment. An additional search for studies on genetic mechanisms involved in development of PCa in AA men was also performed.

Results:

Eleven studies on pathologic results of AA men who would qualify for AS were identified and in eight of these studies AA race was found to be associated with adverse pathological outcomes such as positive surgical margins, upgrading or upstaging. The other three studies reported no significance in these parameters with respect to race. Five more studies reported outcomes of AS in AA men with different study end points. AA men were mainly found to have a higher rate of disease reclassification subsequent to active treatment. The studies on genetic mechanisms also identified different genetic alterations in the AA population.

Conclusions:

AA men with clinically defined low-risk PCa may have either a higher grade or volume of cancer that was not detected on routine evaluation. Therefore, AS among such patients should be approached with caution. We recommend discussing such risks with AA patients with an acknowledgement that existing favorable outcomes noted in largely Caucasian populations may not be applicable to AA patients. We propose a modified evaluation plan for AA patients that includes an early confirmatory biopsy preceded by an magnetic resonance imaging to optimally detect occult cancer foci.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  1. Cooperberg MR, Broering JM, Kantoff PW, Carroll PR . Contemporary trends in low risk prostate cancer: risk assessment and treatment. J Urol 2007; 178: S14–S19.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Epstein JI, Walsh PC, Carmichael M, Brendler CB . Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer. JAMA 1994; 271: 368–374.

    Article  CAS  PubMed  Google Scholar 

  3. Alemozaffar M, Regan MM, Cooperberg MR, Wei JT, Michalski JM, Sandler HM et al. Prediction of erectile function following treatment for prostate cancer. JAMA 2011; 306: 1205–1214.

    Article  CAS  PubMed  Google Scholar 

  4. Sanda MG, Dunn RL, Michalski J, Sandler HM, Northouse L, Hembroff L et al. Quality of life and satisfaction with outcome among prostate-cancer survivors. N Engl J Med 2008; 358: 1250–1261.

    Article  CAS  PubMed  Google Scholar 

  5. Dall'Era MA, Albertsen PC, Bangma C, Carroll PR, Carter HB, Cooperberg MR et al. Active surveillance for prostate cancer: a systematic review of the literature. Eur Urol 2012; 62: 976–983.

    Article  PubMed  Google Scholar 

  6. Tosoian JJ, Mamawala M, Epstein JI, Landis P, Wolf S, Trock BJ et al. Intermediate and longer-term outcomes from a prospective active-surveillance program for favorable-risk prostate cancer. J Clin Oncol 2015; 33: 3379–3385.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Cooperberg MR, Carroll PR . Trends in management for patients with localized prostate cancer, 1990-2013. JAMA 2015; 314: 80–82.

    Article  CAS  PubMed  Google Scholar 

  8. Iremashvili V, Soloway MS, Rosenberg DL, Manoharan M . Clinical and demographic characteristics associated with prostate cancer progression in patients on active surveillance. J Urol 2012; 187: 1594–1599.

    Article  PubMed  Google Scholar 

  9. Chornokur G, Dalton K, Borysova ME, Kumar NB . Disparities at presentation, diagnosis, treatment, and survival in African American men, affected by prostate cancer. Prostate 2011; 71: 985–997.

    Article  PubMed  Google Scholar 

  10. Siegel RL, Miller KD, Jemal A . Cancer statistics, 2015. CA Cancer J Clin 2015; 65: 5–29.

    Article  PubMed  Google Scholar 

  11. Ha YS, Salmasi A, Karellas M, Singer EA, Kim JH, Han M et al. Increased incidence of pathologically nonorgan confined prostate cancer in African-American men eligible for active surveillance. Urology 2013; 81: 831–835.

    Article  PubMed  Google Scholar 

  12. Sundi D, Ross AE, Humphreys EB, Han M, Partin AW, Carter HB et al. African American men with very low-risk prostate cancer exhibit adverse oncologic outcomes after radical prostatectomy: should active surveillance still be an option for them? J Clin Oncol 2013; 31: 2991–2997.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Sundi D, Kryvenko ON, Carter HB, Ross AE, Epstein JI, Schaeffer EM . Pathological examination of radical prostatectomy specimens in men with very low risk disease at biopsy reveals distinct zonal distribution of cancer in black American men. J Urol 2014; 191: 60–67.

    Article  PubMed  Google Scholar 

  14. Faisal FA, Sundi D, Cooper JL, Humphreys EB, Partin AW, Han M et al. Racial disparities in oncologic outcomes after radical prostatectomy: long-term follow-up. Urology 2014; 84: 1434–1441.

    Article  PubMed  Google Scholar 

  15. Vora A, Large T, Aronica J, Haynes S, Harbin A, Marchalik D et al. Predictors of Gleason score upgrading in a large African-American population. Int Urol Nephrol 2013; 45: 1257–1262.

    Article  PubMed  Google Scholar 

  16. Mahal BA, Aizer AA, Ziehr DR, Hyatt AS, Choueiri TK, Hu JC et al. Racial disparities in prostate cancer-specific mortality in men with low-risk prostate cancer. Clin Genitourin Cancer 2014; 12: e189–e195.

    Article  PubMed  Google Scholar 

  17. Yamoah K, Deville C, Vapiwala N, Spangler E, Zeigler-Johnson CM, Malkowicz B et al. African American men with low-grade prostate cancer have increased disease recurrence after prostatectomy compared with Caucasian men. Urol Oncol 2015; 33: 70 e15–22.

    Article  Google Scholar 

  18. Weiner AB, Patel SG, Eggener SE . Pathologic outcomes for low-risk prostate cancer after delayed radical prostatectomy in the United States. Urol Oncol 2015; 33: 164 e111–164 e167.

    Article  Google Scholar 

  19. Resnick MJ, Canter DJ, Guzzo TJ, Brucker BM, Bergey M, Sonnad SS et al. Does race affect postoperative outcomes in patients with low-risk prostate cancer who undergo radical prostatectomy? Urology 2009; 73: 620–623.

    Article  CAS  PubMed  Google Scholar 

  20. Jalloh M, Myers F, Cowan JE, Carroll PR, Cooperberg MR . Racial variation in prostate cancer upgrading and upstaging among men with low-risk clinical characteristics. Eur Urol 2015; 67: 451–457.

    Article  PubMed  Google Scholar 

  21. Schreiber D, Chhabra A, Rineer J, Weedon J, Schwartz D . A population-based study of men with low-volume low-risk prostate cancer: does African-American race predict for more aggressive disease? Clin Genitourin Cancer 2015; 13: e259–e264.

    Article  PubMed  Google Scholar 

  22. Moul JW, Connelly RR, Mooneyhan RM, Zhang W, Sesterhenn IA, Mostofi FK et al. Racial differences in tumor volume and prostate specific antigen among radical prostatectomy patients. J Urol 1999; 162: 394–397.

    Article  CAS  PubMed  Google Scholar 

  23. Sanchez-Ortiz RF, Troncoso P, Babaian RJ, Lloreta J, Johnston DA, Pettaway CA . African-American men with nonpalpable prostate cancer exhibit greater tumor volume than matched white men. Cancer 2006; 107: 75–82.

    Article  PubMed  Google Scholar 

  24. Truong M, Slezak JA, Lin CP, Iremashvili V, Sado M, Razmaria AA et al. Development and multi-institutional validation of an upgrading risk tool for Gleason 6 prostate cancer. Cancer 2013; 119: 3992–4002.

    Article  PubMed  Google Scholar 

  25. Freedland SJ, Kane CJ, Amling CL, Aronson WJ, Terris MK, Presti JC Jr. et al. Upgrading and downgrading of prostate needle biopsy specimens: risk factors and clinical implications. Urology 2007; 69: 495–499.

    Article  PubMed  Google Scholar 

  26. Kane CJ, Im R, Amling CL, Presti JC Jr., Aronson WJ, Terris MK et al. Outcomes after radical prostatectomy among men who are candidates for active surveillance: results from the SEARCH database. Urology 2010; 76: 695–700.

    Article  PubMed  Google Scholar 

  27. Leapman MS, Freedland SJ, Aronson WJ, Kane CJ, Terris MK, Walker K et al. Pathological and biochemical outcomes among African-American and Caucasian men with low risk prostate cancer in the SEARCH Database: implications for active surveillance candidacy. J Urol 2016; 196: 1408–1414.

    Article  PubMed  PubMed Central  Google Scholar 

  28. Lubeck DP, Litwin MS, Henning JM, Stier DM, Mazonson P, Fisk R et al. The CaPSURE database: a methodology for clinical practice and research in prostate cancer. CaPSURE Research Panel. Cancer of the Prostate Strategic Urologic Research Endeavor. Urology 1996; 48: 773–777.

    Article  CAS  PubMed  Google Scholar 

  29. Abern MR, Bassett MR, Tsivian M, Banez LL, Polascik TJ, Ferrandino MN et al. Race is associated with discontinuation of active surveillance of low-risk prostate cancer: results from the Duke Prostate Center. Prostate Cancer Prostatic Dis 2013; 16: 85–90.

    Article  CAS  PubMed  Google Scholar 

  30. Odom BD, Mir MC, Hughes S, Senechal C, Santy A, Eyraud R et al. Active surveillance for low-risk prostate cancer in African American men: a multi-institutional experience. Urology 2014; 83: 364–368.

    Article  PubMed  Google Scholar 

  31. Sundi D, Faisal FA, Trock BJ, Landis PK, Feng Z, Ross AE et al. Reclassification rates are higher among African American men than Caucasians on active surveillance. Urology 2015; 85: 155–160.

    Article  PubMed  Google Scholar 

  32. Davis JW, Ward JF 3rd, Pettaway CA, Wang X, Kuban D, Frank SJ et al. Disease reclassification risk with stringent criteria and frequent monitoring in men with favourable-risk prostate cancer undergoing active surveillance. BJU Int 2015; 118: 68–76.

    Article  PubMed  PubMed Central  Google Scholar 

  33. Wilt TJ, Brawer MK, Jones KM, Barry MJ, Aronson WJ, Fox S et al. Radical prostatectomy versus observation for localized prostate cancer. N Engl J Med 2012; 367: 203–213.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Nelson WG, De Marzo AM, Yegnasubramanian S . Epigenetic alterations in human prostate cancers. Endocrinology 2009; 150: 3991–4002.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Woodson K, Hayes R, Wideroff L, Villaruz L, Tangrea J . Hypermethylation of GSTP1, CD44, and E-cadherin genes in prostate cancer among US Blacks and Whites. Prostate 2003; 55: 199–205.

    Article  CAS  PubMed  Google Scholar 

  36. Woodson K, Hanson J, Tangrea J . A survey of gene-specific methylation in human prostate cancer among black and white men. Cancer Lett 2004; 205: 181–188.

    Article  CAS  PubMed  Google Scholar 

  37. Castro P, Creighton CJ, Ozen M, Berel D, Mims MP, Ittmann M . Genomic profiling of prostate cancers from African American men. Neoplasia 2009; 11: 305–312.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Cher ML, Lewis PE, Banerjee M, Hurley PM, Sakr W, Grignon DJ et al. A similar pattern of chromosomal alterations in prostate cancers from African-Americans and Caucasian Americans. Clin Cancer Res 1998; 4: 1273–1278.

    CAS  PubMed  Google Scholar 

  39. Rose AE, Satagopan JM, Oddoux C, Zhou Q, Xu R, Olshen AB et al. Copy number and gene expression differences between African American and Caucasian American prostate cancer. J Transl Med 2010; 8: 70.

    Article  PubMed  PubMed Central  Google Scholar 

  40. Petrovics G, Zhang W, Makarem M, Street JP, Connelly R, Sun L et al. Elevated expression of PCGEM1, a prostate-specific gene with cell growth-promoting function, is associated with high-risk prostate cancer patients. Oncogene 2004; 23: 605–611.

    Article  CAS  PubMed  Google Scholar 

  41. Yamoah K, Johnson MH, Choeurng V, Faisal FA, Yousefi K, Haddad Z et al. Novel biomarker signature that may predict aggressive disease in African American men with prostate cancer. J Clin Oncol 2015; 33: 2789–2796.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  42. Wallace TA, Prueitt RL, Yi M, Howe TM, Gillespie JW, Yfantis HG et al. Tumor immunobiological differences in prostate cancer between African-American and European-American men. Cancer Res 2008; 68: 927–936.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

    M I Gökce, D Sundi & C Pettaway

  2. Department of Urology, Ankara University School of Medicine, Ankara, Turkey

    M I Gökce

  3. Department of Urology, The Northwestern University, Evanston, IL, USA

    E Schaeffer

Authors
  1. M I Gökce
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. D Sundi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. E Schaeffer
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. C Pettaway
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to M I Gökce or C Pettaway.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gökce, M., Sundi, D., Schaeffer, E. et al. Is active surveillance a suitable option for African American men with prostate cancer? A systemic literature review. Prostate Cancer Prostatic Dis 20, 127–136 (2017). https://doi.org/10.1038/pcan.2016.56

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/pcan.2016.56

This article is cited by

Search

Advanced search

Quick links